HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Spain Health Consumer

Spain’s OTC Market Goes Into Reverse After COVID-19 Sales Spike

  • Data

Executive Summary

Sales of self-care products in Spain have dropped below 2019 levels after a huge spike in demand in March as a result of the coronavirus pandemic. However, sales of paracetamol still remain markedly above 2019 levels.

You may also be interested in...



The Bubble Bursts: Germany’s OTC Market Slumps As COVID-19 Impact Deepens

After an almost 50% rise in sales in March, Germany's OTC market suffered a severe contraction in April as the 'boom' effect of the coronavirus wore off, according to data from Sempora Consulting. 

Spain Lists Certain OTCs As 'Essential' In Fight Against COVID-19

Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.

EMA Quashes Claims That Ibuprofen Worsens Infection From Coronavirus

Breaking News: The European Medicines Agency says there is no evidence that ibuprofen worsens Covid‑19 and that consumers can carry on using the drug as advised by patient information. 

Table

View full table

Topics

Tags:
Spain Health Consumer
Latest News

Nicotine Gummies Sold For Smoking Cessation Doused Under US FDA Tobacco Regulations

Warning Confirms Some Supplement GMP Violations Remain Common In US

ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach

Don’t Get Caught In Long-COVID OTC Painkiller ‘Hamster Wheel,’ Warn German Neurologists

See All
UsernamePublicRestriction

Register

RS149911

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By